Share This Link

Headache can be a side effect of dopamine infusion but does not necessarily indicate the need to increase the infusion rate. It is important to monitor and manage the headache, but it is not a direct indicator of inadequate perfusion or shock management.

Chest pain is a concerning symptom that requires immediate evaluation but is not directly related to the need to increase dopamine infusion. Chest pain could indicate myocardial ischemia or other cardiac issues, which may require different interventions.

Extravasation refers to the leakage of dopamine into the surrounding tissue, which can cause local tissue damage. This is a complication of IV therapy and requires immediate attention, but it does not indicate the need to increase the infusion rate. Instead, the infusion site should be assessed, and appropriate measures should be taken to prevent further extravasation.

Use the Z-track method to administer the medication is typically used for intramuscular injections to prevent medication from leaking back into the subcutaneous tissue. It is not appropriate for subcutaneous heparin injections and does not help minimize bleeding.

Gently massage the site following the injection is not recommended for heparin injections as it can increase the risk of bleeding and bruising. Massaging the site can cause the medication to spread into the surrounding tissue, leading to hematoma formation.

Aspirate the syringe prior to injecting the heparin is not necessary for subcutaneous injections and can increase the risk of bleeding. Aspiration is typically done for intramuscular injections to ensure the needle is not in a blood vessel, but it is not required for subcutaneous heparin administration.

Frequency is clearly stated as every 12 hours, which is a common dosing interval for ondansetron. There is no need to clarify this part of the prescription.

Route is specified as by mouth, which is an appropriate and common route of administration for ondansetron. This part of the prescription does not require clarification.

Dose is specified as 8 mg, which is within the typical dosing range for ondansetron. There is no need to clarify this part of the prescription.

Ensure the NPH insulin is drawn into the syringe first is incorrect. The short-acting insulin should be drawn into the syringe first to avoid contaminating it with NPH insulin.

Use two separate syringes to mix the insulin is not necessary. Insulin can be mixed in one syringe as long as the correct procedure is followed.

Administer the insulin within 20 minutes of preparing it is not specific to the mixing procedure. Insulin should generally be administered promptly after preparation, but the exact timing can vary.

Valerian is an herbal supplement commonly used for its sedative effects. It does not have a significant interaction with warfarin and is not contraindicated for concurrent use.

Probiotics are generally safe to use with warfarin and do not have a significant impact on its anticoagulant effects. They are not contraindicated for concurrent use.

Coenzyme Q10 is structurally similar to vitamin K and can potentially reduce the effectiveness of warfarin. However, it is not as strongly contraindicated as ginkgo biloba, which has a more pronounced effect on bleeding risk.

Famotidine is an H2 receptor antagonist used to treat conditions like ulcers and gastroesophageal reflux disease (GERD). It does not contain sulfonamide and is generally safe for patients with sulfonamide allergies.

Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief, fever reduction, and anti-inflammatory purposes. It does not contain sulfonamide and is not contraindicated for patients with sulfonamide allergies.

Metronidazole is an antibiotic used to treat various infections, including those of the gastrointestinal tract and the reproductive system. It does not contain sulfonamide and is safe for patients with sulfonamide allergies.

Document the administration of the medication is an important step but should be done after the medication has been administered to ensure accurate record-keeping.

Compare the amount of medication available to the inventory record is necessary to ensure that the correct amount of medication is being administered and to prevent discrepancies. However, it is not the first step in the process.

Remove the medication from the medication dispensing cabinet is a necessary step but should be done after verifying the client’s identity to ensure the correct medication is given to the right patient.

Monitor the client’s thyroid function levels is not relevant to the administration of metformin, as metformin does not affect thyroid function.

Collect the client’s uric acid level is not necessary in this context, as metformin does not typically impact uric acid levels.

Obtain the client’s HDL level is not relevant to the administration of metformin, as metformin does not directly affect HDL levels.

Administer the medication while wearing protective footwear is not a standard precaution for administering hazardous IV medications. Protective footwear is generally used to prevent physical injuries rather than chemical exposure.

Wear an N95 respiratory mask when administering the medication is necessary for airborne precautions but not typically required for administering hazardous IV medications unless there is a risk of aerosolization.

Administer the medication in a negative pressure room is used for airborne infection isolation but is not a standard requirement for administering hazardous IV medications.

Absence of peripheral neuropathy is not an indicator of ondansetron’s effectiveness. Ondansetron is used to prevent nausea and vomiting, not to treat neuropathy.

Increased urinary output is not related to the effectiveness of ondansetron. This medication does not affect urinary output.

Reduced dizziness can be a beneficial effect but is not the primary indication of ondansetron’s effectiveness. Ondansetron is primarily used to prevent nausea and vomiting.